Aetera Medical Family OfficeAETERAMedical Family Office
预约15分钟首页关于我们医疗家族办公室服务流程长寿医学再生医疗企业家健康全球医疗资源医学专家库知识中心会员体系联系日本語中文EN
Regenerative medicine advisory and medical due diligence

AETERA Medical Family Office

再生医疗路径判断,而不是治疗项目推广

AETERA 帮助客户理解、评估和判断再生医疗相关选择。我们不提供治疗、诊断或结果承诺。

Medical Risk Statement

理解再生医疗

再生医疗是一个快速发展的领域,并非所有疗法都具有相同证据等级。适配性、风险、收益和监管因素会因患者、机构和司法辖区而异。任何医疗决策都应与合格医生讨论后作出。

Definition

什么是再生医疗?

再生医学关注组织修复、功能恢复、细胞治疗、外泌体研究、组织工程与再生科学。它不是单一项目,也不应被简化为抗衰服务。AETERA 将其放在医学证据、医生评估、机构标准、监管边界和长期随访中理解。

AETERA Position

保持好奇、谨慎和知情判断。

面对再生医疗,应保持好奇、谨慎和基于信息的判断。AETERA 的角色不是推广治疗,而是帮助客户理解选择,并做出更好的长期健康决策。

Evidence

理解证据等级

Evidence LevelDescription
Established Clinical PracticeWidely used within appropriate indications and supported by mature clinical standards.
Emerging Clinical ApplicationsGrowing evidence, but suitability and standards still require careful physician assessment.
Investigational ResearchLimited or study-specific evidence; should be understood through research design and consent.
Experimental ConceptsEarly-stage ideas that should not be presented as routine care or guaranteed outcomes.

Japan

日本再生医疗

日本有再生医疗相关法规框架,医疗机构需遵循相应监管要求。不同项目适用不同规则,是否适合需由医生判断。再生医疗的监管状态取决于具体程序、机构和适用法规。

Suitability

再生医疗适合所有人吗?

不一定。年龄、既往病史、诊断、治疗目标和医生评估都会影响适配性。AETERA 不预设再生医疗适合每一个人。

Decision Framework

AETERA 如何看待再生医疗

01

Understand the objective

02

Review medical history

03

Assess available evidence

04

Evaluate institutional standards

05

Discuss risks and limitations

06

Coordinate information gathering

07

Support informed decision-making

常见问题

What is regenerative medicine?

Regenerative medicine is a field that studies tissue repair, functional recovery, cellular mechanisms, and regenerative science. It is not a single treatment or a guaranteed anti-aging solution.

What is stem cell therapy?

Stem cell therapy refers to medical or research approaches that use cells or cell-related mechanisms. Suitability, evidence, cell source, processing standards, and regulatory documentation must be reviewed carefully.

What are exosomes?

Exosomes are extracellular vesicles involved in cell communication. They are widely discussed in research, but clinical claims require careful review of evidence, preparation standards, and applicable regulation.

Are regenerative therapies suitable for everyone?

No. Age, diagnosis, medical history, treatment goals, contraindications, and physician assessment all influence suitability.

How is patient suitability evaluated?

Suitability is evaluated through medical history, current diagnosis, laboratory and imaging data, risk factors, goals, alternative options, and physician judgment.

What questions should I ask before considering treatment?

Ask about evidence level, indication, expected benefit, risks, alternatives, physician credentials, institution standards, regulatory documents, follow-up, and adverse-event management.

What are the potential risks?

Risks vary by procedure and patient. They may include infection, immune reaction, inappropriate indication, poor-quality preparation, uncertain benefit, delayed standard care, or inadequate follow-up.

How does Japan regulate regenerative medicine?

Japan has regulatory frameworks related to regenerative medicine. The status of a specific procedure depends on the procedure, institution, physician responsibility, documentation, and applicable rules.

Is regenerative medicine legal in Japan?

It should not be simplified that way. The regulatory status depends on the specific procedure, institution, and applicable regulations.

Can AETERA provide medical advice?

No. AETERA provides education, coordination, record preparation, and decision support. Medical advice, diagnosis, and treatment decisions must come from qualified physicians.

Does AETERA guarantee treatment outcomes?

No. AETERA does not guarantee outcomes, reverse aging claims, cure claims, or suitability for any regenerative medicine option.

Does AETERA sell stem cell or exosome programs?

No. AETERA's role is not to promote treatments. Our role is to help clients understand options, risks, evidence, and decision pathways.

What documents should be reviewed?

Relevant documents may include medical records, lab reports, imaging, medication history, consent forms, institution materials, physician background, regulatory documentation, and follow-up plans.

Why do evidence levels matter?

Evidence levels help clients distinguish mature clinical practice from emerging applications, investigational research, and early-stage concepts.

How can a Medical Family Office help?

A Medical Family Office helps organize information, ask better questions, review risk boundaries, coordinate qualified opinions, and support long-term family health decisions.

Better medical decisions begin with better questions.

AETERA helps families turn complex regenerative medicine information into a clearer, physician-led decision pathway.

申请私密顾问沟通